DRG Fingertip insights
보험 플랜, 정책 제한, PBM, 의료 제공자 등 마켓 액세스 의사결정에 필요한 데이터와 인사이트를 제공합니다.
Report
2011년 10월 11일
Formulary Advantages in Atrial Fibrillation: How Will MCO Size Affect the Design of Factor Xa Formularies?
In the coming years, atrial fibrillation (AF) patients will increasingly have more choice for anticoagulation therapy. Although Boehringer Ingelheim’s Pradaxa (dabigatran etexilate) and emerging facto…
Report
2011년 9월 28일
Formulary Advantages in Asthma and COPD Therapies: Formulary Advantages in Asthma and COPD Therapies – Abstract
The market for asthma and chronic obstructive pulmonary disease (COPD) has grown notably in recent years because of increasing prevalence and diagnosis rates for both conditions as well as the greater…
Report
2011년 8월 16일
Formulary Advantages in Psychiatric Drugs: Medicare plans readily employ cost-sharing measures and formulary restrictions to direct early use of generics and preferred brands for psychiatry.
According to the National Institute of Mental Health, each year tens of millions of Americans are affected by mental illness. Although significant strides have been made toward understanding the patho…
